CCND1 and gastric cancer: Introduction of anti-miR-9 inhibitor into these cells resulted in enhanced abilities in proliferation (Fig. S3B) and cell cycle progression (Fig. S3C). These results indicated that miR-9 remarkably suppressed the in vitro proliferation and cell cycle progression of gastric cancer cells through targeting cyclin D1.